AU3725893A - TNF inhibitors - Google Patents

TNF inhibitors

Info

Publication number
AU3725893A
AU3725893A AU37258/93A AU3725893A AU3725893A AU 3725893 A AU3725893 A AU 3725893A AU 37258/93 A AU37258/93 A AU 37258/93A AU 3725893 A AU3725893 A AU 3725893A AU 3725893 A AU3725893 A AU 3725893A
Authority
AU
Australia
Prior art keywords
tnf inhibitors
tnf
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37258/93A
Inventor
Peter Lawrence Demarsh
Klaus Max Esser
Carrie Lynn Frey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU3725893A publication Critical patent/AU3725893A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
AU37258/93A 1992-02-21 1993-02-19 TNF inhibitors Abandoned AU3725893A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US839838 1986-03-13
US83983892A 1992-02-21 1992-02-21

Publications (1)

Publication Number Publication Date
AU3725893A true AU3725893A (en) 1993-09-13

Family

ID=25280753

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37258/93A Abandoned AU3725893A (en) 1992-02-21 1993-02-19 TNF inhibitors

Country Status (4)

Country Link
AU (1) AU3725893A (en)
MX (1) MX9300959A (en)
WO (1) WO1993016699A1 (en)
ZA (1) ZA931222B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6930101B1 (en) 1999-05-17 2005-08-16 The Regents Of The University Of California Thiazolopyrimidines useful as TNFα inhibitors
KR101100601B1 (en) * 2004-02-14 2011-12-29 글락소스미스클라인 엘엘씨 Novel compounds
CA2618963A1 (en) 2005-08-10 2007-02-15 Smithkline Beecham Corporation Xanthine derivatives as selective hm74a agonists
LT3251675T (en) * 2015-01-30 2021-07-12 Shanton Pharma Pte. Ltd. Prevention or treatment of uric acid or gout disease
WO2023187607A1 (en) 2022-03-29 2023-10-05 Universidade Nova De Lisboa Nickel n-heterocyclic carbene complexes based on xanthines and use therof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906792D0 (en) * 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds

Also Published As

Publication number Publication date
MX9300959A (en) 1994-08-31
ZA931222B (en) 1993-11-29
WO1993016699A1 (en) 1993-09-02

Similar Documents

Publication Publication Date Title
AU2067892A (en) Corrosion inhibitors
AU5533094A (en) Enzyme inhibitors
AU8292091A (en) Tnf inhibitors
AU4166393A (en) Auto-reclosers
AU648907B2 (en) Corrosion inhibitors
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU4177593A (en) Benzophenonehydrazones
AU685767B2 (en) Substituted benzazepinones
AU3042892A (en) Rockbolt
AU667580B2 (en) Line-handling block
AU4156393A (en) Heterocyclyltriazolinones
ZA919178B (en) Tnf inhibitors
AU664253B2 (en) Photo-deviometer
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU3461693A (en) Saddle-cloth
AU4164793A (en) Heterocyclyltriazolinones
AU3725893A (en) TNF inhibitors
AU4632493A (en) Weathershed
AU8694291A (en) Ester inhibitors
AU3185693A (en) Pyrrolylbenzodiazepinones
AU4864693A (en) Alkoxymethyl-substituted pyridonebiphenyls
AU5156793A (en) Eosinophil infiltration inhibitor
AU5564794A (en) Play-mark
AU4316993A (en) Polyaniles